Physician profile
Mohammed Moon
NPI 1578509329
$4,610.56
in general payments reported to CMS, 2019-2025
38 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $685 · 2020: $445 · 2021: $945 · 2022: $962 · 2023: $728 · 2024: $444 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.97 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $986.41 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $457.05 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $405.45 | 2019-2023 | Spravato, Xarelto |
| Abbvie INC. | $386.54 | 2020-2023 | |
| Glaxosmithkline, LLC. | $370.61 | 2020-2024 | Arexvy |
| Braintree Laboratories, INC. | $274.25 | 2019-2023 | Suflave |
| Redhill Biopharma INC. | $197.39 | 2020-2022 | |
| Pfizer INC. | $153.69 | 2019-2024 | |
| Abbott Laboratories | $149.58 | 2019-2024 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $115.36 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $107.55 | 2022 | |
| Novo Nordisk INC | $90.39 | 2022-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $79.98 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $67.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $67.26 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.